 |
| Welcome to the Home page of the ESTP ! |
|
| |
Cutting Edge Pathology
We are currently facing a never seen and very difficult situation worldwide.
Please see a letter from ESTP, ESVP and ECVP chairs and their Scientific and Local Organizing Committees, informing you about the decision to postpone our joint Cutting Edge Pathology congress by one year, to the end of August / beginning of September 2021 in Torino, Italy.
We are sure that you understand the necessity to make this decision. We ensure you to inform you as soon as possible about the new dates for the congress in Torino.
This year's Annual General Assembly will be conducted virtually (GoTo webinar format), on 27th August 2020, from 2:00 to 4:00 pm CEST.
As ESTP member you have received the invitation by email. Approximately 2 weeks prior to the AGA, you will receive a GoTo invitation to register and instructions how to join the event.
We wish you and your families all the best, above all health and patience during these challenges times.
|
Further ESTP news and announcements:
 |
|
|
 ESTP newsletter 2020 (1)
The first ESTP newsletter 2020 containing a President's column, announcements of the ESTP Annual General Assembly and electronic voting for ESTP Executive Committee, short informations on the 7th and 8th ESTP Expert Workshops and Pathology 2.0 Committee as well as a look back to the ESTP Classic Examples 2020 in Hannover is now available here. Previous newsletters are accessible in the repository.
[27-May-2020
]
|
 Guess What!
Case #27
Interesting cases from the field of toxicologic pathology are presented each year in this interactive ESTP section. The new case #27 is now available.
[08-May-2020
]
|
|
|
[30-Aug-2019
]
|
|
|
The ESTP Committee for Scientific Standards (CSS) prepared a response to the recently published FDA guidance "Pathology Peer Review in Nonclinical Toxicology Studies: Questions and Answers, Guidance for Industry". This draft guidance was published in the Federal register August 1st, 2019 for public comment and originated from the FDA Office of Study Integrity and Surveillance (OSIS). Herewith, we would also like to thank you those members and organizations, which have shared their comments and responses regarding this Draft guidance with us.
The finalized ESTP CSS comments have been endorsed by the ESTP Executive Committee, and were submitted electronically and by UPS to the FDA October 18th, 2019. The committee had agreed with FDA representatives an extension of the official comment period.
If you have any questions or comments, please reach out to the working group chair, Annette Romeike (annette.romeike@covance.com).
Annette Romeike, ESTP Chair of Committee for Scientific Standards, on behalf of the ESTP CSS – Sibylle Groeters, Laetita Elies, Erio Barale, Eveline de Rijk, Katrin Gutberlet, Flavia Pasello
[18-Nov-2019
]
|
|
|
|
|
17th European Congress of Toxicologic Pathology
Revision of Standardized Nomenclature